Hepatoprotective pathway

The hepatoprotective pathway encompasses various cellular and molecular mechanisms that collectively protect the liver from a variety of insults, including drugs, toxins, metabolic stress, and immune-mediated damage. Key components include the IL-6/STAT3 signaling axis (important for anti-apoptotic and regenerative effects), the Keap1-Nrf2 pathway (central to antioxidant defense), and SIRT1-regulated signaling (implicated in metabolic regulation and apoptosis suppression)[1][2][4][7]. Numerous drugs and phytochemicals, such as silymarin, glycyrrhizin, and curcumin, exert their protective effects by modulating these pathways. The hepatoprotective pathway is not a single molecular entity or canonical "target," but a conceptual grouping of mechanisms relevant to liver health and therapeutic intervention[1][2][4][5][6][7]. Summary: "Hepatoprotective pathway" is not a discrete molecular target, but rather a non-canonical, functional term representing protective processes in the liver. If structured data on a specific molecular target involved in hepatoprotection (like "Nuclear factor erythroid 2-related factor 2" or "Signal transducer and activator of transcription 3") is needed, more specific querying is recommended[1][2][4][5][7].

Other names

Hepatoprotective signalingLiver protection pathwayHepatic protection mechanisms

Activation of antioxidant pathways (e.g., Keap1-Nrf2); Inhibition of pro-inflammatory cytokine signaling (e.g., IL-6/STAT3, NF-kB); Enhancement of anti-apoptotic proteins; Inhibition of caspases and reduction of oxidative damage; Regulation of mitochondrial function; Upregulation of hepatic regeneration